Random Clinical Pearls CPJE Exam Review 2024/2025 A+ Graded

Random Clinical Pearls CPJE Exam Review 2024/2025 A+ Graded Anakinra (Kineret) dosing freq - ANS-Once daily SQ IL-1 receptor antagonist, Biological DMARDs For: RA Etanercept (Enbrel) dosing freq - ANS-Once or twice weekly Bio DMARD Adalimumab (Humira) dosing freq - ANS-once weekly or every 2 weeks SQ Golimumab (Simponi) dosing freq - ANS-once monthly SQ Tocilizumab (Actemra) - ANS-once weekly or every 2 weeks SQ Hydroxychloroquine advantage vs caution - ANS-advantage: lack of hepatic or renal toxicity & lack of myelosuppression caution: may cause vision change or hearing change Leflunomide (Arava) advantage vs caution - ANS-advantage: can be removed by cholesteyramine or activated charcoal caution: Preg cat X and hepatotoxic Continues...